Upcoming vascular framework.
RE: Upcoming Vascular Framework
I am writing to you on behalf of the Clinical Engagement and Implementation Managers (CEIMs) for NHS Supply Chain Rehabilitation, Disabled Services, Women’s Health and Associated Consumables, Tower 5 provided by Collaborative Procurement Partnership LLP (CPP).
The CEIM team members are a clinical team employed by CPP and are fundamental to delivering the new NHS Supply Chain Operating Model. The team has been brought together from a range of NHS and procurement organisations, including theatre practitioners, nurses with acute sector experience and paramedics. Team members have extensive experience of working in clinical procurement roles at national, regional and local levels. Our role is to develop and apply a formal and transparent process of clinically evaluating healthcare products to identify those that deliver quality, safety and value to the NHS.
To deliver this, we have developed a 5-stage evaluation process:
The results of the evaluation will be published in the format of a product report and will be published in the NHS Supply Chain catalogue.
The process will be assured by the Clinical and Product Assurance (CaPA) function of Supply Chain Coordination Limited (SCCL).
The role of the Clinical and Product Assurance (CaPA) function of SCCL is to perform clinical assurance on behalf of SCCL.
SCCL is committed to providing a clinically assured, safe and optimised product range for the health and social care system which meets the needs of Allied Health and Care Professionals (AHCP), patients, carers.
When are we evaluating?
All Rehabilitation, Disabled Services, Women’s Health and Associated Consumables are currently associated to a national contract/framework. The vascular framework is currently under evaluation and includes;
- Graduated Compression Stockings (GCS)
- Leg Ulcer Kits
- Anti-Embolism Stockings (AES)
- Intermittent Pneumatic Compression (IPC)
We are keen to engage with relevant clinical staff prior to the expiry of current contracts to understand the product scope in the market place.
How will we develop the evaluation criteria?
The evaluation criteria will be developed to ensure they are objective and measurable. They will reflect what the clinical/end users tell us they need the product to do, to ensure the delivery of care which is safe, represents value for money and provides a quality patient and end user experience.
To build evaluation criteria we will run a series of national engagement activities with clinical stakeholders of the products including, for example, workshops, individual consultations, online surveys and webinars for NHS clinicians.
We will undertake an independent review of the current literature/evidence base and along with technical and supporting literature from suppliers merge all this intelligence into a set of evaluation criteria.
Why are we writing to you now?
We are now at the beginning of our process and are collecting intelligence on products.
It is vitally important we have feedback from yourselves, colleagues and networks and we now invite you to kindly share with us your feedback. If you would like to share your knowledge and experience, could you please complete the attached survey and share the link with colleagues.
If you would like to join our national network of clinical staff keen to be involved with the process, please email email@example.com with your details or those of any interested colleagues.
As you will appreciate, we need to conduct this process with rigour and in a timely fashion.
For this reason, we would greatly appreciate your co-operation if you could ensure your submission is received within the next two weeks, ideally returned by 15 May.
Thank you for your support.
Clinical Evaluation and Implementation Team
NHS Supply Chain: Rehabilitation, Disabled Services, Women’s Health and Associated Consumables.
Provided by Collaborative Procurement Partnership LLP